PUBLICATIONS · 15284263
Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2004 Aug 1
- First author
- Markman M
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Markman M
- type
- Author
- name
- Markman J
- type
- Author
- name
- Webster K
- type
- Author
- name
- Zanotti K
- type
- Author
- name
- Kulp B
- type
- Author
- name
- Peterson G
- type
- Author
- name
- Belinson J
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Markman M
- type
- Author
- name
- Markman J
- type
- Author
- name
- Webster K
- type
- Author
- name
- Zanotti K
- type
- Author
- name
- Kulp B
- type
- Author
- name
- Peterson G
- type
- Author
- name
- Belinson J
- type
- Author
- bibliography ids
- nci-bib-cbf1bb609500ee0a9518b4f5
- book metadata
- content sha256
- 6224a6a61f6cfb982370ba7da5af1781ecb14d6304fb62a3ad0bb5efd25e1fdc
- document type
- citation
- dois
- 10.1200/JCO.2004.05.195
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:15284263
- immutable id
- pubmed:15284263@6224a6a61f6cfb982370ba7da5af1781ecb14d6304fb62a3ad0bb5efd25e1fdc
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 15
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3120-5
- volume
- 22
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 15284263
- provenance
- batch id
- 748437a772c9631ad901
- provider
- NCBI PubMed ESummary
- record sha256
- 02e18d62f04ebc7a05792941fe0809ecd746c0723d2a7b3d13a08168a3f67aad
- response sha256
- 1535c16de1ca2ef53b01ccf9e7709049035aa1b159955f06fbec3d1a0daddc80
- retrieved at
- 2026-09-09T23:45:55.399079+00:00
- publication date
- display
- 2004 Aug 1
- precision
- day
- year
- 2004
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design.
Preserved source evidence · Not medical advice
Triangle